SCHEMBL25106981

SCHEMBL25106981

Cc1cnc2nc(N)ccc2n1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 5/20 0.41
NCK1 P16333 1/20 0.41
NOS2 P35228 4/20 0.39
NOS3 P29474 3/20 0.39
NOS1 P29475 1/20 0.39
KDM4E B2RXH2 2/20 0.37
LMNA P02545 1/20 0.37
POLB P06746 1/20 0.37
CASP6 P55212 1/20 0.37
PLAU P00749 1/20 0.35
NCF1 P14598 3/20 0.34
ALDH1A1 P00352 2/20 0.33
CTSD P07339 1/20 0.33
CASP1 P29466 1/20 0.33
CASP7 P55210 1/20 0.33
HSD17B10 Q99714 1/20 0.33
GABRP O00591 1/20 0.32
GABRD O14764 1/20 0.32
GABRA1 P14867 1/20 0.32
GABRB1 P18505 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4045372 0.81 PLAU (0.43) BACE1NCK1NOS2PLAUNCF1
SCHEMBL24284152 0.81 CYP1A2 (0.43) KDM4ELMNAPOLBCASP6ALDH1A1
SCHEMBL25933730 0.76 CYP1A2 (0.31) ALDH1A1CYP1A2MET
SCHEMBL25449341 0.76 BACE1 (0.38) BACE1NCK1NOS2NOS3NOS1
SCHEMBL5802570 0.72 NOS2 (0.48) BACE1NCK1NOS2NOS3NOS1
SCHEMBL25748417 0.72 BACE1 (0.54) BACE1NCK1NOS2NOS3NOS1
SCHEMBL6644292 0.70 PLAU (0.40) BACE1NCK1NOS2NOS3NOS1
SCHEMBL31663159 0.70 PLAU (0.40) BACE1NCK1NOS2NOS3NOS1
SCHEMBL3638905 0.70 PLAU (0.40) BACE1NCK1NOS2NOS3NOS1
SCHEMBL14656791 0.69 KDM4E (0.38) BACE1NOS2NOS3NOS1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023025912-A1 USE OF GCN2 INHIBITORS IN TREATING CANCER Alesta Therapeutics BV (NL) 2023-03-02 WO disclosed